Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dentsply Sirona (XRAY) Income towards Parent Company (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Income towards Parent Company for 17 consecutive years, with -$145.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company rose 66.12% year-over-year to -$145.0 million, compared with a TTM value of -$598.0 million through Dec 2025, up 34.29%, and an annual FY2025 reading of -$598.0 million, up 34.29% over the prior year.
  • Income towards Parent Company was -$145.0 million for Q4 2025 at Dentsply Sirona, up from -$428.0 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $110.0 million in Q1 2021 and bottomed at -$1.1 billion in Q3 2022.
  • Average Income towards Parent Company over 5 years is -$110.2 million, with a median of $6.5 million recorded in 2024.
  • The sharpest move saw Income towards Parent Company tumbled 1382.14% in 2022, then skyrocketed 580.0% in 2023.
  • Year by year, Income towards Parent Company stood at $92.0 million in 2021, then crashed by 116.3% to -$15.0 million in 2022, then surged by 580.0% to $72.0 million in 2023, then crashed by 694.44% to -$428.0 million in 2024, then skyrocketed by 66.12% to -$145.0 million in 2025.
  • Business Quant data shows Income towards Parent Company for XRAY at -$145.0 million in Q4 2025, -$428.0 million in Q3 2025, and -$44.0 million in Q2 2025.